Rate control during atrial fibrillation achieved by chronic endocardial vagal stimulation: Proof of principle

Heart Rhythm

Volumn 6, Issue 9, 2009, Pages 1287-1288

  McComb, Janet M ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

CATHETER ABLATION; COMPLETE HEART BLOCK; EDITORIAL; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART FAILURE; HEART PACING; HUMAN; NONHUMAN; PRIORITY JOURNAL; PULMONARY VEIN; THERAPY EFFECT; VAGUS NERVE STIMULATION; VEIN SURGERY; ATRIAL FIBRILLATION; DEVICE SAFETY; ELECTRODE IMPLANT; ENDOCARDIUM; HEART RATE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INNERVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON, CORONARY; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; ELECTRODES, IMPLANTED; ENDOCARDIUM; EQUIPMENT SAFETY; HEART FAILURE; HEART RATE; HUMANS; VAGUS NERVE STIMULATION;

EID: 69049104530     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.05.023     Document Type: Editorial

References (20)

1. Anter E., Jessup M., and Callans D.J. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation 119 (2009) 2516-2525
2. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) study. JAMA 285 (2001) 2370-2375
3. Redfield M.M., Jacobsen S.J., Burnett Jr. J.C., Mahoney D.W., Bailey K.R., and Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289 (2003) 194-202
4. Wang T.J., Larson M.G., Levy D., et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107 (2003) 2920-2925
5. de Denus S., Sanoski C.A., Carlsson J., Opolski G., and Spinler S.A. Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis. Arch Intern Med 165 (2005) 258-262
6. Roy D., Talajic M., Nattel S., et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358 (2008) 2667-2677
7. Bianchi S., Rossi P., Della Scalla A., et al. Atrioventricular node vagal stimulation by transvenous permanent lead implantation to modulate AV node function: safety and feasibility in humans. Heart Rhythm 6 (2009) 1282-1286
8. Mazgalev T.N., Garrigue S., Mowrey K.A., Yamanouchi Y., and Tchou P.J. Autonomic modification of the atrioventricular node during atrial fibrillation: role in the slowing of ventricular rate. Circulation 99 (1999) 2806-2814
9. Zhuang S., Zhang Y., Mowrey K.A., et al. Ventricular rate control by selective vagal stimulation is superior to rhythm regularization by atrioventricular nodal ablation and pacing during atrial fibrillation. Circulation 106 (2002) 1853-1858
10. Wallick D.W., Zhang Y., Tabata T., et al. Selective AV nodal vagal stimulation improves hemodynamics during acute atrial fibrillation in dogs. Am J Physiol Heart Circ Physiol 281 (2001) H1490-H1497
11. Zhang Y., and Mazgalev T. Achieving regular slow rhythm during atrial fibrillation without atrioventricular nodal ablation: selective vagal stimulation plus ventricular pacing. Heart Rhythm 1 (2004) 469-475
12. Zhang Y., Yamada H., Bibevski S., et al. Chronic atrioventricular nodal vagal stimulation: first evidence for long-term ventricular rate control in canine atrial fibrillation model. Circulation 112 (2005) 2904-2911
13. Schauerte P., Scherlag B.J., Scherlag M.A., Goli S., Jackman W.M., and Lazzara R. Ventricular rate control during atrial fibrillation by cardiac parasympathetic nerve stimulation: a transvenous approach. J Am Coll Cardiol 34 (1999) 2043-2050
14. Rossi P., Bianchi S., Barretta A., et al. Post-operative atrial fibrillation management by selective epicardial vagal fat pad stimulation. J Interv Card Electrophysiol 24 (2009) 37-45
15. Quan K.J., Van Hare G.F., Biblo L.A., Mackall J.A., and Carlson M.D. Endocardial stimulation of efferent parasympathetic nerves to the atrioventricular node in humans: optimal stimulation sites and the effects of digoxin. J Interv Card Electrophysiol 5 (2001) 145-152
16. Bianchi S., Rossi P., Della Scala A., and Kornet L. Endocardial transcatheter stimulation of the AV nodal fat pad: stabilization of rapid ventricular rate response during atrial fibrillation in left ventricular failure. J Card Electrophysiol 20 (2009) 103-105
17. Soos P., Merkely B., Horvat P., Zima E., and Schauerte P. Determinants and effects of electrical stimulation of the inferior interatrial parasympathetic plexus during atrial fibrillation. J Cardiovasc Electrophysiol 16 (2005) 1362-1367
18. Daubert J.P., Zareba W., Cannom D.S., et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 51 (2008) 1357-1365
19. Knight B.P., Desai A., Coman J., Faddis M., and Yong P. Long-term retention of cardiac resynchronization therapy. J Am Coll Cardiol 44 (2004) 72-77
20. Gasparini M., Auricchio A., Regoli F., et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 48 (2006) 734-743